Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study

BACKGROUND: Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear. METHODS: This was a population-based cohort study in 2005–2015. Associations between metformin use and gastric non-cardia and cardia adenocarcinomas were examined within two cohorts; a diabetes c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jiaojiao, Xie, Shao-Hua, Santoni, Giola, Lagergren, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889304/
https://www.ncbi.nlm.nih.gov/pubmed/31591459
http://dx.doi.org/10.1038/s41416-019-0598-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889304/
https://www.ncbi.nlm.nih.gov/pubmed/31591459
http://dx.doi.org/10.1038/s41416-019-0598-z

Ejemplares similares